VisualDx CEO Flags Decades-Old Diagnostic Blind Spot in Skin of Color
At Fall Clinical Derm 2026, VisualDx's CEO spotlighted a decades-old blind spot in diagnosing disease on skin of color, pressing practices to close the gap.
Topic
Topic
At Fall Clinical Derm 2026, VisualDx's CEO spotlighted a decades-old blind spot in diagnosing disease on skin of color, pressing practices to close the gap.
A twelve-month intake analysis from a resident-run free dermatology clinic in Cleveland offers a rare structured look at the skin…
42.6% of 136 countries reported climate-driven changes in skin disease prevalence or severity, with low-income nations nearly twi…
An October 2026 JID perspective by Parker and Cole-Adeife maps how climate change drives infectious, autoinflammatory, and neopla…
A Springer-published study analyses how well dedicated ethnic and skin of colour dermatology textbooks represent the full range o…
A Medscape report argues that global skin equity in dermatology demands targeted, population-specific strategies rather than broa…
AI tools have entered dermatology practice, but real-world validation, workflow integration and accountability now decide their c…
Andrew Alexis, MD, MPH, tells AJMC that new therapies are shifting the landscape for skin of color dermatology, signaling expandi…
Everyday Health outlines what people of color should weigh before joining an atopic dermatitis trial, from EASI-based eligibility…